Sign in
4

Changes in Ownership

Stoke Therapeutics, Inc. Filed Acc 0001144204-19-032095

10% owner acquired 671,808 shares (conversion)

From the SEC's structured data for this filing

Trades in this filing

Redmile Group, LLC · 10% owner

Table I: Non-derivative

1 line
Date Transaction Shares Owned after D/I
2019-06-21 Conversion : show line 1 in the form +671,808 671,808 I

Table II: Derivative

1 line
Date Transaction Shares Underlying Owned after D/I
2019-06-21 Conversion : show line 2 in the form Series B Convertible Preferred Stock −671,808 671,808 0 I
Loading xslF345X03/tv524091_4.xml…